The two companies plan to secure required initial regulatory approvals in individual African territories before expanding to other areas in the region.
An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.